RA Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

RA Capital Management’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-80,515	Closed	-$33.8M	–	32
2019 Q1	$33.8M	Hold	80,515	–	–	1.46%	20
2018 Q4	$24.5M	Buy	+80,515	New	+$26M	1.43%	20
2017 Q2	–	Sell	-11,807	Closed	-$4.06M	–	26
2017 Q1	$4.06M	Hold	11,807	–	–	0.5%	23
2016 Q4	$4.13M	Hold	11,807	–	–	0.58%	22
2016 Q3	$4.74M	Buy	11,807 +2,084	+21%	+$1.06M	0.49%	26
2016 Q2	$5.78M	Hold	9,723	–	–	0.8%	24
2016 Q1	$4.89M	Buy	+9,723	New	+$4.84M	0.63%	32
2015 Q2	–	Sell	-91	Closed	-$775K	–	67
2015 Q1	$775K	Hold	91	–	–	0.08%	55
2014 Q4	$799K	Buy	+91	New	+$528K	0.1%	49

Other funds holding EIGR

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return